Capital raised by Neutrolis
2 Form D filings · first filed Feb 2025 · Cambridge, MA
Chief Executive Officer of the Issuer
Signatory on Neutrolis's Form D filings · $4.5M raised across 2
Anthony Aiudi is on file as Chief Executive Officer of the Issuer at Neutrolis in Cambridge, MA. Neutrolis has 2 Form D filings on record, $4.5M raised in total. Anthony Aiudi appears as a signatory on the company's filings.
The exDNASE™ platform is Neutrolis’s proprietary technology designed to engineer enzymes specifically for the degradation of Neutrophil Extracellular Traps (NETs). This platform is pivotal in developing therapies that can mitigate the damaging effects of overactive neutrophils in autoimmune and inflammatory diseases.
